RxDoctor Payments Data

Brittany Morehead, APRN

Family · Columbus, INNPI 1528620325

Payments from drug & device makers

$3,641in general payments, 2019–2025

Across 263 payments — averaging $13.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$951
  • Johnson & Johnson$252
  • Takeda Pharmaceuticals U.S.A., Inc.$221
  • Sanofi$177
  • Ironwood Pharmaceuticals, Inc$139
  • plus $671 from 13 others

What the payments were for

  • Food & beverage$3,641100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,641 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Medicare billing

Part B allowed, 2024
$36,453
Medicare patients
385
Services billed
459

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
CreonLipase/Protease/Amylase25$127,131
XifaxanRifaximin12$49,011
LinzessLinaclotide49$46,982
Budesonide DrBudesonide56$11,376
MotegrityPrucalopride Succinate11$6,287
Colestipol Hcl33$3,559
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates48$3,356
Sucralfate17$3,338
Mesalamine ErMesalamine17$3,093
Dexlansoprazole DrDexlansoprazole14$3,055
Esomeprazole Magnesium37$3,017
ClenpiqSod Picosulf/Mag Ox/Citric Ac16$2,751
Pantoprazole Sodium222$2,559
Budesonide EcBudesonide18$2,517
Lactulose35$2,295

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieCreon, Linzess$1,230$174,11374 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$951$49,01112 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$221$6,28711 claims
Ferring Pharmaceuticals Inc.Clenpiq$73$2,75116 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,392 family providers in Indiana.

Other family in Columbus

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →